CancerLinQ SmartLinQ™ solutions save time, enabling practitioners to focus on providing care with seamless participation in ASCO’s flagship quality program, ASCO Certified™
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced its initiative, CancerLinQ®, is now a recognized quality solution for clinical quality measures data for ASCO Certified. As an ASCO Recognized Quality Solution (RQS) provider, CancerLinQ automates quality tracking for ASCO Certified practices, saving clinical teams an average of 4-20 hours a week (depending on the practice size) from manual abstraction, redirecting time for patient care. ASCO RQS enables CancerLinQ’s oncology practices to more easily submit quality measure data for ASCO Certified—creating a frictionless experience for health system and oncology practice partners. Achieving this recognition demonstrates CancerLinQ’s dedication to data integrity, supporting oncology practice partners and improving patient care.
A Commitment to Data Quality
ASCO RQS identifies technology and data providers that offer quality data products and resources to oncology practices. Through this recognition, oncology practices have a reliable and easy way to comply with ASCO Certified data requirements. As a newly recognized ASCO RQS provider, CancerLinQ can submit clinical quality measures data on behalf of oncology practices participating in ASCO Certified—ASCO’s flagship quality program that certifies outpatient oncology practices and health systems to meet comprehensive standards for patient-centered care. The program also serves as a next-generation quality measurements initiative, enabling oncology practices to review quality, outcomes and utilization measures from electronic health records, insurance claims, patient satisfaction surveys and evidence-based treatment pathways. With its newly acquired status, CancerLinQ serves as a gateway to this comprehensive program for partners to achieve ASCO Certified status.
Better Tracking and More Time for Patient Care
The automation replaces manual abstraction typically performed by administrators, quality managers, clinicians, or nurses, freeing up time and resources for patient care. Unlike traditional quality audits that review only sample cases, CancerLinQ’s automation provides comprehensive tracking across all eligible patients, enabling end-to-end assessment of care quality. The program also offers internal and external benchmarking capabilities, allowing practices to compare their performance against similar sites and identify specific care gaps that need improvement.
Without this automation, practices face either manual chart abstraction that captures only sample patients or no quality measurement at all. This comprehensive tracking empowers ASCO Certified partner sites to demonstrate value to patients, insurance companies and other stakeholders while maintaining competitiveness through measurable quality outcomes.
“Oncologists knew they provided a really high level of quality care, but they didn’t have the time to manually measure it in full,” said Dr. Robert S. Miller, chief medical science officer at CancerLinQ. “We’ve given them one less thing to worry about, so they will have more time to focus on providing the best possible care to their patients.”
Becoming an RQS Data Provider
CancerLinQ underwent a rigorous validation process that reviewed necessary data elements for clinical quality measurement and demonstrated a commitment to data quality. CancerLinQ leverages real-world data from over 9 million patients to deliver actionable insights and standardized quality measures that identify and close care gaps, while supporting clinical trial screening and evidence-based treatment plans that improve patient outcomes and promote efficiency.
“This recognition is another stellar step in ConcertAI’s decade-long collaboration with ASCO and our dedication to supporting the CancerLinQ community with reliable, high-quality data solutions,” said Eron Kelly, CEO of ConcertAI. “Being an RQS provider positions us to help more practices deliver evidence-based, patient-centered care while harnessing the power of AI to drive better outcomes.”
To apply to become an ASCO RQS data provider and to receive resources, contact cdr@asco.org [Attn: Recognized Quality Solution]. For oncology practices and cancer centers interested in joining the growing CancerLinQ network, contact info@cancerlinq.org.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!